Linda Aurpibul

Dr. Linda Aurpibul

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Journal of the International AIDS Society
Verified
Journal Article
Open access
PDF file
TSTavitiya Sudjaritruk
Tavitiya Sudjaritruk
Linda AurpibulLinda Aurpibul
Linda Aurpibul
WSWipaporn Natalie Songtaweesin
Wipaporn Natalie Songtaweesin
ANAssawin Narkpongphun
Assawin Narkpongphun
PTPaul Thisayakorn
Paul Thisayakorn
TGthe Mental Health Study Group
the Mental Health Study Group
Introduction: To assess the burden of depression, anxiety and suicidality; and to determine the impact of integrated mental health and HIV services on treatment outcomes among Thai adolescents and young adults living with HIV (AYHIV).Methods: A multicentre prospective cohort study was conducted among AYHIV (15 to 25 years), and age‐ and sex‐matched HIV‐uninfected adolescents and young adults (HUAY). The Patient Health Questionnaire 9‐item (PHQ‐9) and Generalized Anxiety Disorder 7‐item scales (GAD‐7) were used as screening tools for depressive and anxiety symptoms respectively. History of lifetime and recent suicidal ideations/attempts were ascertained. Elevated mental health screening scores were defined as having either significant depressive symptoms (PHQ‐9 ≥9), significant anxiety symptoms (GAD‐7 ≥10) or suicidality (lifetime; and recent [within two weeks]). Participants meeting these criteria were referred to psychiatrists for confirmatory diagnosis and mental health services. Follow‐up assessment with PHQ‐9 and GAD‐7 was performed one year after psychiatric referral.Results: From February to April 2018, 150 AYHIV and 150 HUAY were enrolled, median age was 19.0 (IQR:16.8 to 21.8) years and 56% lived in urban areas. Among AYHIV, 73% had HIV RNA <50 copies/mL, and median CD4 count was 580 (IQR:376 to 744) cells/mm3. At enrolment, 31 AYHIV (21%; 95%CI:14% to 28%) had elevated mental health screening scores; 17 (11%) significant depressive symptoms, 11 (7%) significant anxiety symptoms and 21 (14%) suicidality. Seven AYHIV (5%) had all three co‐existing conditions. These prevalences were not substantially different from HUAY. Urban living increased risk, whereas older age decreased risk of elevated mental health screening scores (p < 0.05). All AYHIV with elevated mental health screening scores were referred to study psychiatrists, and 19 (13%; 95%CI: 8% to 19%) had psychiatrist‐confirmed mental health disorders (MHDs), including adjustment disorder (n = 5), major depression (n = 4), anxiety disorders (n = 2), post‐traumatic stress disorder (n = 1) and mixed MHDs (n = 4). One year after psychiatric referral, 42% of AYHIV who received mental health services demonstrated an absence of significant mental health symptoms from the reassessments, and 26% had an improved score.Conclusions: With the significant burden of MHDs among AYHIV, an integration of mental health services, including mental health screenings, and psychiatric consultation and referral, is critically needed and should be scaled up in HIV healthcare facilities.

30 March 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Linda AurpibulLinda Aurpibul
Linda Aurpibul
SNSirianong Namwongprom
Sirianong Namwongprom
TSTavitiya Sudjaritruk
Tavitiya Sudjaritruk
SOSakaewan Ounjaijean
Sakaewan Ounjaijean
People living with HIV who are on antiretroviral treatment are at increased risk of developing premature cardiovascular disease. Children with perinatal HIV infection (PHIV) have survived through their adolescence and are entering adulthood. We determined the prevalence of metabolic syndrome, abnormal biochemical markers, and characterized body composition parameters in youth living with perinatal HIV infection. This cross-sectional study was conducted at the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand from December 2017 to February 2018. PHIV-youths between 15 <25 years of age who were receiving ART were enrolled. Data collection included ART-related history, blood pressure, and anthropometric measurements. Body composition including android, gynoid fat mass, and total body fat were measured by dual-energy X-ray absorptiometry. Fasting blood was drawn to test for lipid profile, glucose, and high sensitivity c-reactive protein (hsCRP). One hundred and twenty PHIV-youths (48% female) were enrolled. Their mean age and the median duration on ART were 20.3 (SD2.6) and 14.1 (IQR 10.4–14.9) years, respectively; 76 (63%) were on first-line non-nucleoside reverse transcriptase inhibitors-based regimens. Thirty-three (28%), 74 (62%), and 13 (11%) of PHIV-youths were underweight (BMI < 18.5 kg/m2), normal (BMI 18.5–24.9 kg/m2), and overweight (BMI ≥ 25.0 kg/m2), respectively. The prevalence of metabolic syndrome was 10.6% (95%CI 5.0–16.0). Seventy-six of 113 (67.3%) of PHIV-youths had lipid alteration; the most prevalent types being low HDL (46.9%) and increased triglycerides (27.4%). Overall 43 (35.9%) had increased hsCRP (16.7% with immediate and 19.2% with high risk for CVD). Females had significantly higher percentage of android and gynoid fat, but lower Android to gynoid ratio (AGR) compared to males. There were 77%, 31%, and 21% of PHIV-youths in the overweight, normal weight, and underweight group with AGR in tertile 3, respectively. In conclusion, we documented presence of metabolic syndrome in 10.6% of PHIV-youths on ART. Increase AGR representing abdominal obesity was detected even in youths with normal BMI or underweight.

1 August 2016 in HIV Medicine
Verified
Journal Article
Open access
PDF file
TSTavitiya Sudjaritruk
Tavitiya Sudjaritruk
TBT Bunupuradah
T Bunupuradah
Linda AurpibulLinda Aurpibul
Linda Aurpibul
PKPope Kosalaraksa
Pope Kosalaraksa
NKNia Kurniati
Nia Kurniati
TGthe Bone‐D Study Group
the Bone‐D Study Group
Objectives: This study aimed to determine the prevalence of low bone mass and assess its relationship with abnormal bone turnover among HIV‐infected Asian adolescents.Methods: A multicentre, cross‐sectional study was conducted at four paediatric HIV centres in Thailand and Indonesia. Perinatally HIV‐infected adolescents aged 10–18 years receiving antiretroviral therapy (ART) with virological suppression (HIV RNA < 400 copies/mL) were enrolled. Study assessments included lumbar spine (L2−L4) dual‐energy X‐ray absorptiometry and measurement of bone turnover markers. Bone mineral density (BMD) and bone mineral apparent density (BMAD) Z‐scores were calculated based on Thai normative age‐ and sex‐matched references. Low bone mass was defined as BMD or BMAD Z‐scores ≤ −2.Results: Of 396 participants, 57% were female. The median age was 15.0 [interquartile range (IQR) 13.3–16.9] years, and 73% were in Tanner stage 3−5. At enrolment, the median CD4 T‐cell count was 734 (IQR 581–907) cells/μL, and 37% were on protease inhibitor (PI)‐based regimens. The overall prevalence of lumbar spine BMD and BMAD Z‐scores ≤ −2 were 16.4% and 8.3%, respectively. Z‐scores were lower with older age, female sex, body mass index (BMI) <5th percentile, boosted PI exposure and CD4 T‐cell percentage < 15% before ART initiation. Increased bone turnover markers were inversely associated with BMD and BMAD Z‐scores.Conclusions: Low bone mass was linked to older age, female sex, low BMI, boosted PI exposure, and poor immunological status before ART commencement in our cohort of perinatally HIV‐infected Asian adolescents. Dysregulation of bone turnover was associated with bone demineralization. Screening for low bone mass should be implemented to identify individuals who might benefit from interventions to preserve bone health.

19 May 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
Linda AurpibulLinda Aurpibul
Linda Aurpibul
ATArunrat Tangmunkongvorakul
Arunrat Tangmunkongvorakul
CDChanidapa Detsakunathiwatchara
Chanidapa Detsakunathiwatchara
SMSupunnee Masurin
Supunnee Masurin
ASAngkana Srita
Angkana Srita
WCWalailak Chueakong
Walailak Chueakong
Introduction: Young adults with perinatal HIV (YAPHIV) have survived the long journey of life while living with HIV since early childhood. We explore the HIV disclosure experience and its social effects from their perspectives.Methods: The qualitative study was conducted from June to November 2022 in Chiang Mai, Thailand. Data were collected through individual in-depth semi-structured interviews with 20 YAPHIV at the median age of 25 years. Content analysis was used to identify themes from the interview transcripts.Results: Most participants learned their HIV status from their parents, caregivers, healthcare providers, or other people in community during their childhood. Some were disclosed later in adolescent years. HIV disclosure to others was associated with various experiences in different stages of life. While some YAPHIV decided not to disclose their HIV status to anyone, it also had social effects. Three major themes were identified: (1) positive social effects of HIV disclosure (perceived social acceptance, perceived social support); (2) negative social effects of HIV disclosure (effects on child rearing, schooling, and family relationship); and (3) HIV non-disclosure (anticipated stigma, negative effects on the quality of employment, and relationships). An emerging theme was a need for peer support mentioned by several YAPHIV as they would like to discuss with somebody and share their feelings while living with HIV.Conclusion: HIV disclosure remains challenging for YAPHIV while growing up and moving toward adult milestones. Better understanding their situations and perspectives would allow healthcare providers to provide them with updated HIV knowledge, coping skills, and psychosocial support.

18 December 2020 in International Journal of STD & AIDS
Verified
Journal Article
Closed access
PDF file
Linda AurpibulLinda Aurpibul
Linda Aurpibul
JSJiratchaya Sophonphan
Jiratchaya Sophonphan
KMKathleen Malee
Kathleen Malee
SKStephen J Kerr
Stephen J Kerr
LSLy Penh Sun
Ly Penh Sun
OSon behalf of the PREDICT Resilience study
on behalf of the PREDICT Resilience study
HIV-related enacted stigma and social problems may increase risk for depression and/or behavioral problems among adolescents and young adults with perinatal HIV(AYA-PHIV), yet few studies have explored stigma in AYA-PHIV residing in low-to-middle income regions, including Southeast Asia. We assessed HIV-related enacted stigma and social problems in AYA-PHIV who participated in the RESILIENCE study (clinicaltrials.gov identification: U19AI53741) in Thailand and Cambodia using specific questions during structured in-person interviews. Depression was measured by the Child Depression Inventory for children <15 years, or the Center for Epidemiologic Studies Depression Scales for youth ≥15 years); behavioral problems were measured by the Child Behavior Checklist (CBCL-caregiver report). Among 195 AYA-PHIV (median age 16.9 years), 25.6% reported a lifetime experience of enacted stigma, while 10.8% experienced social problems due to HIV infection. The frequency of depressive symptoms was nearly two-fold higher among AYA-PHIV with compared to those without HIV-related enacted stigma (34.7% vs. 16.0%, p = 0.005). Caregiver-reported behavioral problems were detected in 14.6% of all AYA-PHIV, with no differences between those with and without HIV-related enacted stigma. Low household income and caregiver mental health problems were independent risk factors for depressive symptoms; HIV-related enacted stigma was also associated with increased risk, warranting targeted services to support AYA-PHIV.

1 July 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PHPimpika Hanvatananukul
Pimpika Hanvatananukul
CPChanidapa Prasarakee
Chanidapa Prasarakee
SSSaowalak Sarachai
Saowalak Sarachai
Linda AurpibulLinda Aurpibul
Linda Aurpibul
KSKamolrawee Sintupat
Kamolrawee Sintupat
TSTavitiya Sudjaritruk
Tavitiya Sudjaritruk
To determine the seroprevalence of antibodies against of diphtheria, tetanus, and pertussis among Thai adolescents. A cross-sectional study was conducted among Thai adolescents aged 11-20 years who had completed five doses of DTP-containing vaccine during childhood, either diphtheria toxoid-tetanus toxoid-whole cell pertussis (DTwP) or diphtheria toxoid-tetanus toxoid-acellular pertussis (DTaP). Protective antibodies against diphtheria, tetanus, and pertussis were defined as anti-diphtheria toxoid IgG ≥ 0.1 IU/ml, anti-tetanus toxoid IgG ≥ 0.1 IU/ml, and anti-Bordetella pertussis toxin IgG ≥ 5 IU/ml, respectively. Of 220 adolescents (median age: 16 years), 45% had received a tetanus toxoid-reduced diphtheria toxoid (Td), and none (0%) had received a tetanus toxoid-reduced diphtheria toxoid-acellular pertussis (Tdap) booster vaccines during adolescence. Overall, 50%, 99%, and 57% of adolescents demonstrated protective antibodies against diphtheria, tetanus, and pertussis, respectively. The geometric mean concentration (GMC) of antibodies against diphtheria (P = 0.06) and tetanus (P < 0.001) were higher among adolescents who had received Td vaccine. Nevertheless, the antibody levels against both diseases waned over time, regardless of Td booster vaccination. Likewise, pertussis antibody levels gradually declined after the fifth childhood dose of DTwP/DTaP vaccine. Approximately half of our healthy Thai adolescents did not maintain protective antibodies against diphtheria and pertussis. A booster vaccination with diphtheria toxoid- and/or acellular pertussis-containing vaccines is a crucial strategy to prevent such diseases among this population.